| Product Code: ETC7638454 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Primary Biliary Cholangitis Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Primary Biliary Cholangitis Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Primary Biliary Cholangitis Market - Industry Life Cycle |
3.4 Ireland Primary Biliary Cholangitis Market - Porter's Five Forces |
3.5 Ireland Primary Biliary Cholangitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Ireland Primary Biliary Cholangitis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Ireland Primary Biliary Cholangitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Primary Biliary Cholangitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Ireland Primary Biliary Cholangitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Primary Biliary Cholangitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of primary biliary cholangitis (PBC) in Ireland |
4.2.2 Growing awareness about the disease and available treatment options |
4.2.3 Technological advancements in diagnosis and treatment of PBC |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of advanced treatment options |
4.3.2 Strict regulatory requirements for approval of new PBC therapies |
5 Ireland Primary Biliary Cholangitis Market Trends |
6 Ireland Primary Biliary Cholangitis Market, By Types |
6.1 Ireland Primary Biliary Cholangitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Liver Transplantation, 2021- 2031F |
6.1.4 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.1.5 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Ursodeoxycholic acid (UDCA), 2021- 2031F |
6.1.6 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Obeticholic acid, 2021- 2031F |
6.1.7 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Fibrates, 2021- 2031F |
6.1.8 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Budesonide, 2021- 2031F |
6.2 Ireland Primary Biliary Cholangitis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By FibroScan, 2021- 2031F |
6.2.3 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.2.4 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Cholesterol Test, 2021- 2031F |
6.2.5 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Antibody Test, 2021- 2031F |
6.2.6 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Liver Test, 2021- 2031F |
6.2.7 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Primary Biliary Cholangitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Primary Biliary Cholangitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Primary Biliary Cholangitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Ireland Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Primary Biliary Cholangitis Market Import-Export Trade Statistics |
7.1 Ireland Primary Biliary Cholangitis Market Export to Major Countries |
7.2 Ireland Primary Biliary Cholangitis Market Imports from Major Countries |
8 Ireland Primary Biliary Cholangitis Market Key Performance Indicators |
8.1 Number of diagnosed PBC cases in Ireland |
8.2 Adoption rate of new PBC treatment guidelines by healthcare providers |
8.3 Investment in research and development for PBC therapies |
8.4 Patient adherence to prescribed treatment regimens |
8.5 Patient-reported outcomes and quality of life improvements |
9 Ireland Primary Biliary Cholangitis Market - Opportunity Assessment |
9.1 Ireland Primary Biliary Cholangitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Ireland Primary Biliary Cholangitis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Ireland Primary Biliary Cholangitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Primary Biliary Cholangitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Ireland Primary Biliary Cholangitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Primary Biliary Cholangitis Market - Competitive Landscape |
10.1 Ireland Primary Biliary Cholangitis Market Revenue Share, By Companies, 2024 |
10.2 Ireland Primary Biliary Cholangitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here